Altimmune Inc
ALT
Get informed when a big investor buys or sells
+ FollowMarket Cap$665.1M
Close$
$0.09
97.3% downside
Current Fair Value
97.3% downsideOvervalued by 97.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $665.10 Million |
|---|---|
| Enterprise Value | $637.80 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1 |
| Beta | 0.17 |
| Outstanding Shares | 185,443,736 |
Return
| Return on Equity | -19.35% |
|---|---|
| Return on Assets | -17.40% |
| Return on Invested Capital | -19.47% |
Valuation & Multiples
| P/E Ratio | -4.38 |
|---|---|
| PEG | -143.01 |
| Price to Sales | - |
| Price to Book Ratio | 1.71 |
| Enterprise Value to Revenue | 20574.1 |
| Enterprise Value to EBIT | -6.37 |
| Enterprise Value to Net Income | -7 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | 0.08 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 11, 2026
EPS Estimate
$-0.14
Average shareholder expectationRevenue Estimate
$2,000
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-0.14
Average shareholder expectationRevenue Estimate
$1,750
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.1853▼ 45.77% |
|---|---|
| Total Calls | 2,715,700▲ 116.15% |
| Total Puts | 503,100▼ 37.72% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 121.07%▲ 42.33% |
|---|---|
| Total Invested | $460.79M▲ 115.81% |
| Investors Holding | 221▲ 38.00% |
ESG Score
No data
About Altimmune Inc
CEO: Vipin Garg